http://audiologyonline.ru/stati....30.html
Хирургическая реабилитация слуха методом внутриулитковой имплантации.
Сегодня кохлеарная имплантация выполняется не только у пациентов с врожденной глухотой или приобретенной, вследствие поражения кохлеарного аппарата менингококковой инфекцией или воздействия ототоксических препаратов, но это и возможность реабилитации слуха при таких заболеваниях как отосклероз, болезнь Меньера [4, 5, 8]. Клинические исследования показывают, что при кохлеарной форме отосклероза с выраженной тугоухостью, когда результаты стапедопластики могут вызывать сомнения, а применение слуховых аппаратов не приносит должного эффекта, кохлеарная имплантация является наиболее адекватным методом реабилитации слуха [6].У пациентов при болезни Меньера, с глубокой сенсоневральной тугоухостью, кохлеарная имплантация возможна как до хирургического лечения вестибулярных расстройств (дренирование эндолимфатического мешка, селективная нейроэктомия, лабиринтэктомия), так и после нее [7].7. Cochlear implantation in patients with bilateral Mйniиre’s syndrome / L. R. Lustig, J. Yeagle, J. K. Niparko et al. / / Otol Neurotol. – 2003. – Vol. 24, №3. – Р. 397–403.Добавлено (05.01.2014, 03:12)
---------------------------------------------
Cochlear implantation in patients with bilateral Ménière's syndrome.Lustig LR, Yeagle J, Niparko JK, Minor LB.Author informationAbstractOBJECTIVE:To evaluate the indications and clinical outcomes (audiologic and vestibular) in patients with Ménière's syndrome who have undergone cochlear implantation.STUDY DESIGN:This is a retrospective review of patients at a large tertiary academic medical center.PATIENTS:Nine patients were included in the study with AAO-HNS criteria for diagnosis of Ménière's syndrome as well as bilateral severe to profound sensorineural hearing loss as an indication for undergoing cochlear implantation. Audiologic criteria for implantation were considered in the context of speech recognition performance with well-fit, powerful hearing aids noting large fluctuations in performance levels in some patients. In all cases, the poorer hearing ear was implanted. Seven subjects had bilateral disease and had progressed to profound sensorineural hearing loss. The average age of the patients was 61 years. Six patients had undergone previous surgery to control vertigo, including endolymphatic shunt surgery and vestibular nerve section. No patient had received previous treatment with intra-tympanic gentamicin. Symptoms of Ménière's syndrome had been present in all patients for at least 10 years before implantation.INTERVENTION:Cochlear Implantation.MAIN OUTCOME MEASURES:Pre- and Postoperative audiometric scores (monosyllable words/phonemes, Central Institute for the Deaf (CID) sentences, Hearing in Noise Test (HINT) in quite/noise (+10 db)), pre- and postoperative vestibular symptoms (number of vestibular attacks, aural fullness, tinnitus).RESULTS:Follow-up after implantation ranged from 1 to 5 years. Average 6 month postimplantation scores were: monosyllable words/phonemes = 52%/65%, CID sentences = 82%, HINT in quiet/noise = 70%/50%. Average 1-year postimplant scores were: monosyllable words/phonemes = 60%/76%, CID sentences = 97%, HINT in quiet/noise = 89%/78%. Postoperative speech recognition scores were, on average, substantially greater than preoperative scores. While there were few complications associated with implantation, some patients experienced alterations in their implant performance in association with fluctuations in vestibular symptoms.CONCLUSIONS:Patients with advanced binaural involvement with Ménière's Disease may present a challenge to conventional criteria for cochlear implant candidacy because of fluctuating symptoms. We observed significant benefit over baseline in a consecutive series of patients with Ménière's syndrome who progressed to bilateral, severe-to-profound sensorineural hearing loss and underwent cochlear implantation. Further, previous vestibular surgery, including labyrinthectomy, does not contraindicate cochlear implantation.
Добавлено (05.01.2014, 03:15)
---------------------------------------------
Sequential bilateral cochlear implantation in a patient with bilateral Ménière's disease.Laura K Holden, J Gail Neely, Brenda D Gotter, Karen M Mispagel, Jill B FirsztDepartment of Otolaryngology-Head and Neck Surgery, Washington University, St. Louis, MO, USA.
Journal of the American Academy of Audiology (Impact Factor: 1.63). 04/2012; 23(4):256-68. DOI:10.3766/jaaa.23.4.4Source: PubMedABSTRACT This case study describes a 45-yr-old female with bilateral, profound sensorineural hearing loss due to Ménière's disease. She received her first cochlear implant in the right ear in 2008 and the second cochlear implant in the left ear in 2010. The case study examines the enhancement to speech recognition, particularly in noise, provided by bilateral cochlear implants. Speech recognition tests were administered prior to obtaining the second implant and at a number of test intervals following activation of the second device. Speech recognition in quiet and noise as well as localization abilities were assessed in several conditions to determine bilateral benefit and performance differences between ears. The results of the speech recognition testing indicated a substantial improvement in the patient's ability to understand speech in noise and her ability to localize sound when using bilateral cochlear implants compared to using a unilateral implant or an implant and a hearing aid. In addition, the patient reported considerable improvement in her ability to communicate in daily life when using bilateral implants versus a unilateral implant. This case suggests that cochlear implantation is a viable option for patients who have lost their hearing to Ménière's disease even when a number of medical treatments and surgical interventions have been performed to control vertigo. In the case presented, bilateral cochlear implantation was necessary for this patient to communicate successfully at home and at work.
